Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: A prospective observational study

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Yoo, Dong Eun ^a   Park, Jung Tak ^a   Oh, Hyung Jung ^a   Kim, Seung Jun ^a   Lee, Mi Jung ^a   Shin, Dong Ho ^a   Han, Seung Hyeok ^a   Yoo, Tae Hyun ^a   Choi, Kyu Hun ^a   Kang, Shin Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PROSPECTIVE STUDY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREND STUDY; AGED; BLOOD; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATION;

AGED; BLOOD GLUCOSE; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBSERVATION; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES;

EID: 84856102479     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030072     Document Type: Article

References (26)

1. United States Renal Data System (2010) Atlas of End-Stage Renal Disease in the United States- Introduction. Am J Kidney Dis 52: S212.
2. American Diabetes Association (2011) Standards of medical care in diabetes-2011. Diabetes Care 34 (Suppl 1): S11-61.
3. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
4. UK Prospective Diabetes Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853.
5. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.
6. Wei M, Gaskill SP, Haffner SM, Stern MP, (1998) Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21: 1167-1172.
7. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, et al. (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141: 421-431.
8. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559.
9. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, et al. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360: 129-139.
10. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572.
11. Oomichi T, Emoto M, Tabata T, Morioka T, Tsujimoto Y, et al. (2006) Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 29: 1496-1500.
12. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM, (2006) Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int 70: 1503-1509.
13. Kalantar-Zadeh K, Kopple JD, Regidor DL, Jing J, Shinaberger CS, et al. (2007) A1C and survival in maintenance hemodialysis patients. Diabetes Care 30: 1049-1055.
14. Shurraw S, Majumdar SR, Thadhani R, Wiebe N, Tonelli M, (2010) Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis. Am J Kidney Dis 55: 875-884.
15. Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, et al. (2011) Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol 6: 1041-1048.
16. Wu MS, Yu CC, Wu CH, Haung JY, Leu ML, et al. (1999) Pre-dialysis glycemic control is an independent predictor of mortality in type II diabetic patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 19 (Suppl 2): S179-183.
17. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
19. Watson PE, Watson ID, Batt RD, (1980) Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33: 27-39.
20. Blagg CR, (1991) Importance of nutrition in dialysis patients. Am J Kidney Dis 17: 458-461.
21. Morioka T, Emoto M, Tabata T, Shoji T, Tahara H, et al. (2001) Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24: 909-913.
22. Chung SH, Han DC, Noh H, Jeon JS, Kwon SH, et al. (2010) Risk factors for mortality in diabetic peritoneal dialysis patients. Nephrol Dial Transplant 25: 3742-3748.
23. Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L, (1986) Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron 42: 133-140.
24. Wade CE, (2008) Hyperglycemia may alter cytokine production and phagocytosis by means other than hyperosmotic stress. Crit Care 12: 182.
25. Bopp C, Bierhaus A, Hofer S, Bouchon A, Nawroth PP, et al. (2008) Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit Care 12: 201.
26. Jin DC, (2011) Current status of dialysis therapy in Korea. Korean J Intern Med 26: 123-131.